» Articles » PMID: 20431077

Prevalence of Asymptomatic Carotid Artery Stenosis in the General Population: an Individual Participant Data Meta-analysis

Overview
Journal Stroke
Date 2010 May 1
PMID 20431077
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: In the discussion on the cost-effectiveness of screening, precise estimates of severe asymptomatic carotid stenosis are vital. Accordingly, we assessed the prevalence of moderate and severe asymptomatic carotid stenosis by age and sex using pooled cohort data.

Methods: We performed an individual participant data meta-analysis (23 706 participants) of 4 population-based studies (Malmö Diet and Cancer Study, Tromsø, Carotid Atherosclerosis Progression Study, and Cardiovascular Health Study). Outcomes of interest were asymptomatic moderate (> or =50%) and severe carotid stenosis (> or =70%).

Results: Prevalence of moderate asymptomatic carotid stenosis ranged from 0.2% (95% CI, 0.0% to 0.4%) in men aged <50 years to 7.5% (5.2% to 10.5%) in men aged > or =80 years. For women, this prevalence increased from 0% (0% to 0.2%) to 5.0% (3.1% to 7.5%). Prevalence of severe asymptomatic carotid stenosis ranged from 0.1% (0.0% to 0.3%) in men aged <50 years to 3.1% (1.7% to 5.3%) in men aged > or =80. For women, this prevalence increased from 0% (0.0% to 0.2%) to 0.9% (0.3% to 2.4%).

Conclusions: The prevalence of severe asymptomatic carotid stenosis in the general population ranges from 0% to 3.1%, which is useful information in the discussion on the cost-effectiveness of screening.

Citing Articles

Carotid artery stenosis and ischemic cerebrovascular events after radiotherapy in patients with head and neck cancer.

Taengsakul N, Nivatpumin P, Chotchutipan T, Tungfung S PLoS One. 2025; 20(1):e0314861.

PMID: 39883632 PMC: 11781643. DOI: 10.1371/journal.pone.0314861.


Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis.

Chudek J, Pospiech M, Chudek A, Holecki M, Puzianowska-Kuznicka M Diagnostics (Basel). 2025; 15(2).

PMID: 39857103 PMC: 11764218. DOI: 10.3390/diagnostics15020219.


Subsequent Acute Ischemic Stroke in a Patient with Monocular Vision Loss Associated with Isolated Internal Carotid Artery Occlusion: A Case Report.

Seetge J, Cseke B, Karadi Z, Szalai E, Gaal V, Szapary L Neurol Int. 2025; 17(1.

PMID: 39852768 PMC: 11767241. DOI: 10.3390/neurolint17010003.


Manifestations of human atherosclerosis across vascular beds.

Jovin D, Sumpio B, Greif D JVS Vasc Insights. 2025; 2.

PMID: 39822712 PMC: 11737335. DOI: 10.1016/j.jvsvi.2024.100089.


Prevalence and associated risk factors of carotid plaque and artery stenosis in China: a population-based study.

Zeng Q, Zhang C, Liu X, Yang S, Ma M, Tang J Front Med. 2024; 19(1):64-78.

PMID: 39601960 DOI: 10.1007/s11684-024-1088-0.


References
1.
. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273(18):1421-8. View

2.
Inzitari D, Eliasziw M, Gates P, Sharpe B, Chan R, Meldrum H . The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 2000; 342(23):1693-700. DOI: 10.1056/NEJM200006083422302. View

3.
Derdeyn C, Powers W . Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke. 1996; 27(11):1944-50. DOI: 10.1161/01.str.27.11.1944. View

4.
Rothwell P . ACST: which subgroups will benefit most from carotid endarterectomy?. Lancet. 2004; 364(9440):1122-3. DOI: 10.1016/S0140-6736(04)17090-6. View

5.
Norris J, Zhu C, Bornstein N, Chambers B . Vascular risks of asymptomatic carotid stenosis. Stroke. 1991; 22(12):1485-90. DOI: 10.1161/01.str.22.12.1485. View